Global and China Cold and Flu Supplement Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: G05FE1EE38CBEN
QYResearch

Abstracts

Global Cold and Flu Supplement Scope and Market Size
Cold and Flu Supplement market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cold and Flu Supplement market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Natural Molecules
• Herbal Extracts
• Vitamins and Minerals
• Others

Market segment by Application, split into

• Online
• Offline

Based on regional and country-level analysis, the Cold and Flu Supplement market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Cold and Flu Supplement market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Wakunaga of America
• Neurobiologix
• The Vitamin Shoppe
• Klaire Labs
• Nordic Naturals
• Himalaya Global Holdings
• Dr. Willmar Schwabe GmbH
• FineVine
• Flora
• Pfizer
• GlaxoSmithKline
• NOW Foods

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Cold and Flu Supplement Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Natural Molecules
  1.2.3 Herbal Extracts
  1.2.4 Vitamins and Minerals
  1.2.5 Others
1.3 Market by Application
  1.3.1 Global Cold and Flu Supplement Market Share by Application: 2020 VS 2026
  1.3.2 Online
  1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Cold and Flu Supplement Market Perspective (2015-2026)
2.2 Global Cold and Flu Supplement Growth Trends by Regions
  2.2.1 Cold and Flu Supplement Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cold and Flu Supplement Historic Market Share by Regions (2015-2020)
  2.2.3 Cold and Flu Supplement Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cold and Flu Supplement Players by Market Size
  3.1.1 Global Top Cold and Flu Supplement Players by Revenue (2015-2020)
  3.1.2 Global Cold and Flu Supplement Revenue Market Share by Players (2015-2020)
3.2 Global Cold and Flu Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cold and Flu Supplement Revenue
3.4 Global Cold and Flu Supplement Market Concentration Ratio
  3.4.1 Global Cold and Flu Supplement Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Cold and Flu Supplement Revenue in 2019
3.5 Key Players Cold and Flu Supplement Area Served
3.6 Key Players Cold and Flu Supplement Product Solution and Service
3.7 Date of Enter into Cold and Flu Supplement Market
3.8 Mergers & Acquisitions, Expansion Plans

4 COLD AND FLU SUPPLEMENT BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cold and Flu Supplement Historic Market Size by Type (2015-2020)
4.2 Global Cold and Flu Supplement Forecasted Market Size by Type (2021-2026)

5 COLD AND FLU SUPPLEMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cold and Flu Supplement Historic Market Size by Application (2015-2020)
5.2 Global Cold and Flu Supplement Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cold and Flu Supplement Market Size (2015-2026)
6.2 North America Cold and Flu Supplement Market Size by Type (2015-2020)
6.3 North America Cold and Flu Supplement Market Size by Application (2015-2020)
6.4 North America Cold and Flu Supplement Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Cold and Flu Supplement Market Size (2015-2026)
7.2 Europe Cold and Flu Supplement Market Size by Type (2015-2020)
7.3 Europe Cold and Flu Supplement Market Size by Application (2015-2020)
7.4 Europe Cold and Flu Supplement Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Cold and Flu Supplement Market Size (2015-2026)
8.2 China Cold and Flu Supplement Market Size by Type (2015-2020)
8.3 China Cold and Flu Supplement Market Size by Application (2015-2020)
8.4 China Cold and Flu Supplement Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Cold and Flu Supplement Market Size (2015-2026)
9.2 Japan Cold and Flu Supplement Market Size by Type (2015-2020)
9.3 Japan Cold and Flu Supplement Market Size by Application (2015-2020)
9.4 Japan Cold and Flu Supplement Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Cold and Flu Supplement Market Size (2015-2026)
10.2 Southeast Asia Cold and Flu Supplement Market Size by Type (2015-2020)
10.3 Southeast Asia Cold and Flu Supplement Market Size by Application (2015-2020)
10.4 Southeast Asia Cold and Flu Supplement Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11 KEY PLAYERS PROFILES

11.1 Wakunaga of America
  11.1.1 Wakunaga of America Company Details
  11.1.2 Wakunaga of America Business Overview
  11.1.3 Wakunaga of America Cold and Flu Supplement Introduction
  11.1.4 Wakunaga of America Revenue in Cold and Flu Supplement Business (2015-2020))
  11.1.5 Wakunaga of America Recent Development
11.2 Neurobiologix
  11.2.1 Neurobiologix Company Details
  11.2.2 Neurobiologix Business Overview
  11.2.3 Neurobiologix Cold and Flu Supplement Introduction
  11.2.4 Neurobiologix Revenue in Cold and Flu Supplement Business (2015-2020)
  11.2.5 Neurobiologix Recent Development
11.3 The Vitamin Shoppe
  11.3.1 The Vitamin Shoppe Company Details
  11.3.2 The Vitamin Shoppe Business Overview
  11.3.3 The Vitamin Shoppe Cold and Flu Supplement Introduction
  11.3.4 The Vitamin Shoppe Revenue in Cold and Flu Supplement Business (2015-2020)
  11.3.5 The Vitamin Shoppe Recent Development
11.4 Klaire Labs
  11.4.1 Klaire Labs Company Details
  11.4.2 Klaire Labs Business Overview
  11.4.3 Klaire Labs Cold and Flu Supplement Introduction
  11.4.4 Klaire Labs Revenue in Cold and Flu Supplement Business (2015-2020)
  11.4.5 Klaire Labs Recent Development
11.5 Nordic Naturals
  11.5.1 Nordic Naturals Company Details
  11.5.2 Nordic Naturals Business Overview
  11.5.3 Nordic Naturals Cold and Flu Supplement Introduction
  11.5.4 Nordic Naturals Revenue in Cold and Flu Supplement Business (2015-2020)
  11.5.5 Nordic Naturals Recent Development
11.6 Himalaya Global Holdings
  11.6.1 Himalaya Global Holdings Company Details
  11.6.2 Himalaya Global Holdings Business Overview
  11.6.3 Himalaya Global Holdings Cold and Flu Supplement Introduction
  11.6.4 Himalaya Global Holdings Revenue in Cold and Flu Supplement Business (2015-2020)
  11.6.5 Himalaya Global Holdings Recent Development
11.7 Dr. Willmar Schwabe GmbH
  11.7.1 Dr. Willmar Schwabe GmbH Company Details
  11.7.2 Dr. Willmar Schwabe GmbH Business Overview
  11.7.3 Dr. Willmar Schwabe GmbH Cold and Flu Supplement Introduction
  11.7.4 Dr. Willmar Schwabe GmbH Revenue in Cold and Flu Supplement Business (2015-2020)
  11.7.5 Dr. Willmar Schwabe GmbH Recent Development
11.8 FineVine
  11.8.1 FineVine Company Details
  11.8.2 FineVine Business Overview
  11.8.3 FineVine Cold and Flu Supplement Introduction
  11.8.4 FineVine Revenue in Cold and Flu Supplement Business (2015-2020)
  11.8.5 FineVine Recent Development
11.9 Flora
  11.9.1 Flora Company Details
  11.9.2 Flora Business Overview
  11.9.3 Flora Cold and Flu Supplement Introduction
  11.9.4 Flora Revenue in Cold and Flu Supplement Business (2015-2020)
  11.9.5 Flora Recent Development
11.10 Pfizer
  11.10.1 Pfizer Company Details
  11.10.2 Pfizer Business Overview
  11.10.3 Pfizer Cold and Flu Supplement Introduction
  11.10.4 Pfizer Revenue in Cold and Flu Supplement Business (2015-2020)
  11.10.5 Pfizer Recent Development
11.11 GlaxoSmithKline
  10.11.1 GlaxoSmithKline Company Details
  10.11.2 GlaxoSmithKline Business Overview
  10.11.3 GlaxoSmithKline Cold and Flu Supplement Introduction
  10.11.4 GlaxoSmithKline Revenue in Cold and Flu Supplement Business (2015-2020)
  10.11.5 GlaxoSmithKline Recent Development
11.12 NOW Foods
  10.12.1 NOW Foods Company Details
  10.12.2 NOW Foods Business Overview
  10.12.3 NOW Foods Cold and Flu Supplement Introduction
  10.12.4 NOW Foods Revenue in Cold and Flu Supplement Business (2015-2020)
  10.12.5 NOW Foods Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Cold and Flu Supplement Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Natural Molecules
Table 4. Key Players of Herbal Extracts
Table 5. Key Players of Vitamins and Minerals
Table 6. Key Players of Others
Table 7. Global Cold and Flu Supplement Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cold and Flu Supplement Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cold and Flu Supplement Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cold and Flu Supplement Market Share by Regions (2015-2020)
Table 11. Global Cold and Flu Supplement Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cold and Flu Supplement Market Share by Regions (2021-2026)
Table 13. Cold and Flu Supplement Market Market Trends
Table 14. Cold and Flu Supplement Market Drivers
Table 15. Cold and Flu Supplement Market Challenges
Table 16. Cold and Flu Supplement Market Restraints
Table 17. Global Cold and Flu Supplement Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Cold and Flu Supplement Market Share by Players (2015-2020)
Table 19. Global Top Cold and Flu Supplement Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cold and Flu Supplement as of 2019)
Table 20. Global Cold and Flu Supplement by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cold and Flu Supplement Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Cold and Flu Supplement Market Size Share by Type (2015-2020)
Table 26. Global Cold and Flu Supplement Revenue Market Share by Type (2021-2026)
Table 27. Global Cold and Flu Supplement Market Size Share by Application (2015-2020)
Table 28. Global Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Cold and Flu Supplement Market Size Share by Application (2021-2026)
Table 30. North America Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Cold and Flu Supplement Market Share by Type (2015-2020)
Table 32. North America Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Cold and Flu Supplement Market Share by Application (2015-2020)
Table 34. North America Cold and Flu Supplement Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Cold and Flu Supplement Market Share by Country (2015-2020)
Table 36. Europe Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Cold and Flu Supplement Market Share by Type (2015-2020)
Table 38. Europe Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Cold and Flu Supplement Market Share by Application (2015-2020)
Table 40. Europe Cold and Flu Supplement Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Cold and Flu Supplement Market Share by Country (2015-2020)
Table 42. China Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 43. China Cold and Flu Supplement Market Share by Type (2015-2020)
Table 44. China Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 45. China Cold and Flu Supplement Market Share by Application (2015-2020)
Table 46. China Cold and Flu Supplement Market Size by Region (US$ Million) (2015-2020)
Table 47. China Cold and Flu Supplement Market Share by Region (2015-2020)
Table 48. Japan Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Cold and Flu Supplement Market Share by Type (2015-2020)
Table 50. Japan Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Cold and Flu Supplement Market Share by Application (2015-2020)
Table 52. Japan Cold and Flu Supplement Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Cold and Flu Supplement Market Share by Country (2015-2020)
Table 54. Southeast Asia Cold and Flu Supplement Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Cold and Flu Supplement Market Share by Type (2015-2020)
Table 56. Southeast Asia Cold and Flu Supplement Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Cold and Flu Supplement Market Share by Application (2015-2020)
Table 58. Southeast Asia Cold and Flu Supplement Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Cold and Flu Supplement Market Share by Country (2015-2020)
Table 60. Wakunaga of America Company Details
Table 61. Wakunaga of America Business Overview
Table 62. Wakunaga of America Product
Table 63. Wakunaga of America Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 64. Wakunaga of America Recent Development
Table 65. Neurobiologix Company Details
Table 66. Neurobiologix Business Overview
Table 67. Neurobiologix Product
Table 68. Neurobiologix Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 69. Neurobiologix Recent Development
Table 70. The Vitamin Shoppe Company Details
Table 71. The Vitamin Shoppe Business Overview
Table 72. The Vitamin Shoppe Product
Table 73. The Vitamin Shoppe Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 74. The Vitamin Shoppe Recent Development
Table 75. Klaire Labs Company Details
Table 76. Klaire Labs Business Overview
Table 77. Klaire Labs Product
Table 78. Klaire Labs Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 79. Klaire Labs Recent Development
Table 80. Nordic Naturals Company Details
Table 81. Nordic Naturals Business Overview
Table 82. Nordic Naturals Product
Table 83. Nordic Naturals Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 84. Nordic Naturals Recent Development
Table 85. Himalaya Global Holdings Company Details
Table 86. Himalaya Global Holdings Business Overview
Table 87. Himalaya Global Holdings Product
Table 88. Himalaya Global Holdings Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 89. Himalaya Global Holdings Recent Development
Table 90. Dr. Willmar Schwabe GmbH Company Details
Table 91. Dr. Willmar Schwabe GmbH Business Overview
Table 92. Dr. Willmar Schwabe GmbH Product
Table 93. Dr. Willmar Schwabe GmbH Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 94. Dr. Willmar Schwabe GmbH Recent Development
Table 95. FineVine Business Overview
Table 96. FineVine Product
Table 97. FineVine Company Details
Table 98. FineVine Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 99. FineVine Recent Development
Table 100. Flora Company Details
Table 101. Flora Business Overview
Table 102. Flora Product
Table 103. Flora Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 104. Flora Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 109. Pfizer Recent Development
Table 110. GlaxoSmithKline Company Details
Table 111. GlaxoSmithKline Business Overview
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 114. GlaxoSmithKline Recent Development
Table 115. NOW Foods Company Details
Table 116. NOW Foods Business Overview
Table 117. NOW Foods Product
Table 118. NOW Foods Revenue in Cold and Flu Supplement Business (2015-2020) (US$ Million)
Table 119. NOW Foods Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cold and Flu Supplement Market Share by Type: 2020 VS 2026
Figure 2. Natural Molecules Features
Figure 3. Herbal Extracts Features
Figure 4. Vitamins and Minerals Features
Figure 5. Others Features
Figure 6. Global Cold and Flu Supplement Market Share by Application: 2020 VS 2026
Figure 7. Online Case Studies
Figure 8. Offline Case Studies
Figure 9. Cold and Flu Supplement Report Years Considered
Figure 10. Global Cold and Flu Supplement Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Cold and Flu Supplement Market Share by Regions: 2020 VS 2026
Figure 12. Global Cold and Flu Supplement Market Share by Regions (2021-2026)
Figure 13. Global Cold and Flu Supplement Market Share by Players in 2019
Figure 14. Global Top Cold and Flu Supplement Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cold and Flu Supplement as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cold and Flu Supplement Revenue in 2019
Figure 16. North America Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Cold and Flu Supplement Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Wakunaga of America Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 44. Neurobiologix Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 45. The Vitamin Shoppe Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 46. Klaire Labs Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 47. Nordic Naturals Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 48. Himalaya Global Holdings Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 49. Dr. Willmar Schwabe GmbH Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 50. FineVine Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 51. Flora Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 52. Pfizer Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 54. NOW Foods Revenue Growth Rate in Cold and Flu Supplement Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed